Transcranial photobiomodulation treats Alzheimer’s disease in amyloid-β protein precursor transgenic mice

Luis De Taboada; Michael R Hamblin

doi:10.1016/b978-0-12-815305-5.00015-4

Related publications

Article2009

Reexamining Alzheimer's Disease: Evidence for a Protective Role for Amyloid-β Protein Precursor and Amyloid-β

Rudy J. Castellani, Hyoung‐gon Lee, Sandra L. Siedlak, Akihiko Nunomura, Takaaki Hayashi, Masao Nakamura, Xiongwei Zhu, George Perry, Mark A. Smith

Article1995

Tau protein directly interacts with the amyloid β-protein precursor: Implications for Alzheimer's disease

Mark A. Smith, Sandra L. Siedlak, Peggy L. Richey, Paul Mulvihill, Jorge Ghiso, Blas Frangione, Fabrizio Tagliavini, Giorgio Giaccone, Orso Bugiani, Darja Praprotnik, Raj N. Kalaria, George Perry

Article1989

Soluble derivatives of the β amyloid protein precursor of Alzheimer's disease are labeled by antisera to the β amyloid protein

Mark R. Palmert, Sandra L. Siedlak, Marcia B. Podlisny, Barry Greenberg, Earl R. Shelton, Hardy Chan, M. Usiak, Dennis J. Selkbe, George Perry, Steven G. Younkin

Letter1988

AMYLOID PRECURSOR PROTEIN IN SENILE PLAQUES OF ALZHEIMER DISEASE

George Perry, Sandra Lipphardt, Madhu Kancherla, Pierluigi Gambetti, Linda Maggiora, Thomas J. Lobl, Paul Mulvihill, Magdalena Mijares, Satish Kumar Sharma, James C. Cornette, Barry Greenberg

Article1998

Amyloid‐β Deposition in Alzheimer Transgenic Mice Is Associated with Oxidative Stress

Mark A. Smith, Keisuke Hirai, Karen Hsiao, Miguel A. Pappolla, Peggy L.R. Harris, Sandra L. Siedlak, Massimo Tabaton, George Perry